ASTCT is dedicated to advancing the field of hematopoietic cell transplantation and cellular therapy through groundbreaking research, high-quality education, impactful advocacy and clinical excellence.
About ASTCT
Access resources to advance your career, discounts on meetings and opportunities to collaborate with colleagues. For a limited time, join ASTCT through Sept. 30, 2026, to access benefits through Dec. 31, 2027.
Join ASTCT
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
The webinar will cover key points from three major Medicare rules: the CY 2027 Outpatient Prospective Payment System (OPPS) proposed rule, the CY 2027 Medicare Physician Fee Schedule (MPFS) proposed rule and the FY 2027 Inpatient Prospective Payment System (IPPS) final rule.
This interactive session will feature a multidisciplinary panel of a nurse, advanced practice providers (APPs), and pharmacists to discuss therapy sequencing strategies for chronic graft-versus-host disease (cGVHD). Through expert dialogue and case-based scenarios, panelists will share real-world approaches, discuss challenges in treatment selection and sequencing, and explore considerations across diverse patient populations and practice settings.
Join the ASTCT Committee on Education and Content for an engaging case discussion featuring a multidisciplinary panel, including a pediatric hematologist, radiologist, and pulmonologist. Panelists will share how they collaborate to evaluate and solve a complex clinical case.
More Meetings
View Meeting Details
New evidence upholds bendamustine as a viable alternative to fludarabine in lymphodepleting (LD) chemotherapy ahead of chimeric antigen receptor (CAR) T-cell treatment.
View More
Browse all Education